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T Cells Expressing Allograft Inflammatory Factor 1 Display
Increased Chemotaxis and Induce a Profibrotic Phenotype in
Normal Fibroblasts In Vitro
Francesco Del Galdo and Sergio A. Jime´nez
Objective. Allograft inflammatory factor 1
(AIF-1) was first identified in rat cardiac allografts
undergoing chronic rejection. The vasculopathy of
chronic allograft rejection is strikingly similar to that
seen in patients with systemic sclerosis (SSc). We
previously demonstrated AIF-1 expression in inflam-
matory cells infiltrating skin and lungs from SSc
patients, but its role in SSc pathogenesis is unknown.
The present study was undertaken to investigate the
effects of AIF-1 on T cell migration and production of
cytokines capable of modulating normal dermal fibro-
blast functions.
Methods. Stably transfected Jurkat T cells ex-
pressing 2 AIF-1 splicing variants were prepared, and
their migration toward fibroblast monolayers assayed in
Transwell cultures. Cytokine production was assessed
by real-time polymerase chain reaction (PCR) and
multiplex enzyme-linked immunosorbent assay. Fibro-
blast gene expression was quantified by real-time PCR,
and collagen production by Western blot analysis of
culture media.
Results. AIF-1 significantly increased Jurkat T
cell migration toward fibroblast monolayers. Expression
of AIF-1 isoform 2 in Jurkat T cells up-regulated their
production of interleukin-4 (IL-4) and IL-17. Condi-
tioned media from AIF-1–expressing clones stimulated
synthesis of types I and III collagen and expression of
IL-6, transforming growth factor , endothelin receptor,
and -smooth muscle actin by normal dermal fibro-
blasts.
Conclusion. These results suggest that AIF-1 may
participate in the early pathogenesis of SSc by promot-
ing tissue T cell infiltration and production of cytokines
capable of inducing the expression of a fibrotic pheno-
type in normal fibroblasts.
Systemic sclerosis (SSc) is a disease of un-
known origin characterized by excessive deposition of
collagen and other connective tissue macromolecules
in skin and multiple internal organs, prominent and
often severe alterations in the microvasculature, and
humoral and cellular immunologic abnormalities. The
most important clinical manifestations of SSc are
caused by the exaggerated production of collagen and
other connective tissue components by fibroblasts and
other mesenchymal cells (1–4), resulting in severe and
progressive fibrosis of the affected organs (5,6). There
is strong evidence that chronic tissue inflammation
plays a role in this process (7–9). Prominent mono-
nuclear cell infiltration comprising predominantly
macrophages and oligoclonal, activated CD4 T cells
is apparent in early SSc lesions (9–12). Indeed, the
presence of several cytokines and growth factors of
inflammatory cell origin in the affected tissues in SSc
has been described (13,14).
Numerous studies examining the interplay be-
tween T cells and fibroblasts in the development of
tissue fibrosis and fibroproliferative vasculopathy sug-
gest that activated T cells can trigger fibroblast acti-
vation both by direct contact and by paracrine action
of secreted cytokines (7,14–20). On the other hand,
chemokines secreted by activated fibroblasts can in-
duce chemotaxis of inflammatory cells, contributing to
the amplification of the pathogenetic process
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(19,21,22). Therefore, a generally accepted hypothesis
regarding the pathogenesis of tissue fibrosis in SSc is
that activated T cells specifically infiltrate target
organs and, once in the tissue, they release cytokines
and growth factors, which in turn initiate and/or
perpetuate the fibrotic process as well as the endothe-
lial and vascular alterations (8,9,14,23). Immunohis-
tochemistry and gene expression studies have identi-
fied numerous cytokines, growth factors, and other
polypeptides that are selectively expressed in affected
tissue in SSc and are therefore believed to participate
in its pathogenesis (21,22,24–26). Allograft inflamma-
tory factor 1 (AIF-1) is one of the most recently
identified candidates (27,28).
AIF-1 is an intracellular protein, encoded by a
phylogenetically conserved gene which was first identi-
fied in rat cardiac allografts undergoing chronic rejec-
tion (29,30). AIF-1 thus appears to play a very important
role in the vasculopathy of transplant rejection, a pro-
cess that bears striking resemblance to the vasculopathy
of SSc.
Our group has demonstrated increased expres-
sion of AIF-1 in both skin and lungs of patients with
SSc, particularly in endothelial cells, infiltrating T
lymphocytes, and tissue macrophages (27,28), suggest-
ing that the protein may have a role in SSc pathogen-
esis. Findings of recent genetic association and mi-
croarray gene expression studies have provided strong
support for this notion (31–33); however, the putative
mechanisms that may be involved are not known. In
this study we examined whether the induced expres-
sion of AIF-1 in T cells could increase their migration
toward dermal fibroblasts cultured in monolayers, and
whether soluble factors produced by AIF-1–
expressing T cells could result in increased collagen
production by normal fibroblasts and expression of
molecular markers reflecting a profibrotic phenotype
in vitro.
MATERIALS AND METHODS
Cell lines. Buffy coat preparations were obtained from
the blood bank at Thomas Jefferson University Hospital, in
accordance with Industry Review Board–approved protocols.
Peripheral blood mononuclear cells (PBMCs) were isolated by
centrifugation with Ficoll-Hypaque (Amersham Pharmacia
Biotech, Piscataway, NJ) and processed for RNA extraction.
I-32 Jurkat T cells (a kind gift from Dr. B. Perussia, Thomas
Jefferson University) were cultured in T75 flasks and main-
tained at 6 105 cells/ml in RPMI 1640 supplemented with 5%
fetal bovine serum and glutamine. Fibroblasts cultured from
normal human dermis were obtained from the Scleroderma
Center Tissue Bank, Thomas Jefferson University, and grown
in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal bovine serum, antibiotics, and glutamine (complete
medium) until confluent. Fibroblasts were used at passages
4–10. For real-time polymerase chain reaction (PCR) experi-
ments, fibroblasts were harvested with trypsin–EDTA, washed
in phosphate buffered saline, and then processed for RNA
extraction using an RNeasy kit according to the protocol
Table 1. Primers used in cloning and in real-time PCR studies*
Gene Forward primer Reverse primer
AIF-1 isoform 1 ATGGAGTTTGACCTTAATGGAAATGGC TCAGGGCAACTCAGAGATAGCTTT
AIF-1 isoform 2 ATGGAGTTTGACCTTAATGGAAATGGC TCACATTTTTAGGATGGCAGATCTCTTG
AIF-1 isoform 3 ATGAGCCAAACCAGGGATTTACAG TCAGGGCAACTCAGAGATAGCTTT
-actin TTGCCGACAGGATGCAGAA GCCGATCCACACGGAGTACTT
IL-4 TGCTGCCTCCAAGAACACAA TGTAGAACTGCCGGAGCACA
IL-6 TCCTTCTCCACAAGCGCC AAGGCAGCAGGCAACACC
IL-10 AGGCTACGGCGCTGTCAT GGCATTCTTCACCTGCTCCA
IL-17 CCTCACCTTGGAATCTCCACC GCACTTTGCCTCCCAGATCA
TGF CGAGCCTGAGGCCGACTA AGATTTCGTTGTGGGTTTCCA
TNF CTGGCCCAGGCAGTCAGAT GGGTTTGCTACAACATGGGCTA
IFN TTCAGATGTAGCGGATAATGGAAC TTCTGTCACTCTCCTCTTTCCA
CCR2 GCCACAAGCTGAACAGAGAAAGT GAACGAGATGTGGACAGCATGT
CXCR4 GGAGGGGATCAGTATATACA GAAGATGATGGAGTAGATGG
ET-R CTGCTGCACATCGTCATTGAC AGCTCCAAATGGCCAGTCCT
-SMA TGTATGTGGCTATCCAGGCG AGAGTCCAGCACGATGCCAG
COL1A1 CCTCAAGGGCTCCAACGAG TCAATCACTGTCTTGCCCCA
COL3A1 TTTGGCACAACAGGAAGCTG GGACTGACCAAGATGGGAACAT
* PCR polymerase chain reaction; AIF-1 allograft inflammatory factor 1; IL-4 interleukin-4; TGF transforming growth factor ; TNF
tumor necrosis factor ; IFN  interferon-; ET-R  endothelin receptor; -SMA  -smooth muscle actin.
AIF-1 INDUCTION OF T CELL INFILTRATION AND PROFIBROTIC CYTOKINES IN SSc 3479
recommended by the manufacturer (Qiagen, Valencia, CA),
including a genomic DNA digestion step.
AIF-1 isoform cloning. Total RNA was extracted from
PBMCs from normal donors using an RNeasy kit. Total RNA
(2 g) was reverse transcribed using a Superscript II reverse
transcriptase kit (Invitrogen, San Diego, CA) and amplified
with primers designed to amplify the full-length complemen-
tary DNA of each AIF-1 isoform (Table 1). PCR products
were electrophoresed on 2% agarose gels, and bands of
expected length were eluted, purified, and sequenced to verify
their specificity. PCR products were cloned into pCMV ex-
pression vector, according to the instructions of the manufac-
turer (Invitrogen). Clones were screened by PCR for insertion
and orientation of the insert and resequenced for accuracy.
Plasmids corresponding to AIF-1 isoforms 2 and 3 were
verified by sequencing and were used for further studies. (The
sequences were submitted and published on the NCBI data-
base [Del Galdo F, Artlett C, and Jime´nez SA: accession nos.
EF070983 and EF070982]).
Stable transfectants. I-32 Jurkat T cells were
screened for AIF-1 expression by real-time PCR, using
isoform-specific primers as previously described (28). Four
hundred thousand Jurkat T cells at a concentration of
106/ml were electroporated with 10 g of pCMV plasmids
carrying either AIF-1 isoform 2 or AIF-1 isoform 3 or with
the empty vector, using a BTX ECM-630 electroporator
(Genetronic, San Diego, CA) for 20 msec at 200V and 940
F, in 1-mm–diameter cuvettes. Cells were selected by
culturing for 9 weeks in G-418 medium (Sigma, St. Louis,
MO) at concentrations of 900 g/ml for the first week and
500 g/ml thereafter. Bulk cultures were subcloned by
limiting dilution, and high AIF-1 isoform–expressing clones
were screened by real-time PCR as previously described
(28), selected, and pooled for further studies.
Migration experiments. Migration assays were per-
formed using 6-well Transwell plates with an 8-m–pore-size
polycarbonate filter (Costar, Cambridge, MA), as previously
described (34). Briefly, normal dermal fibroblasts were placed
in the lower chamber and grown to confluence in complete
medium. Stably transfected I-32 Jurkat T cells (2  105) were
loaded in the upper chamber. Transwell plates were then
incubated for 3 hours or 6 hours at 37°C in a 5% CO2
humidified atmosphere. Lower chambers were photographed
using a Zeiss (Wetzlar, Germany) Axiovert 25 microscope
equipped with a Spotcam digital camera. Image files were
acquired with Spot advanced software and stored as jpeg files.
Cell migration rates were determined by counting the Jurkat T
cells that had migrated through the filter into the lower
chamber in 6 random high-power fields (hpf) (200). Exper-
iments were performed in triplicate, examining the migration
of 3 stably transfected pools of Jurkat T cells toward 3 different
normal fibroblast cell lines. Migration inhibition experiments
using a specific anti–monocyte chemotactic protein 1 (anti–
MCP-1) antibody (BioLegend, San Diego, CA) were per-
formed using 5 g of antibody/106 cells as described (35). Cells
migrating into the lower chamber were counted after 3 hours
and 6 hours.
Real-time PCR. AIF-1 isoform and cytokine expres-
sion was verified and quantified using SYBR Green real-
time PCR, as previously described (28). Primers for -actin,
interleukin-4 (IL-4), IL-6, IL-10, IL-17, interferon-
(IFN), transforming growth factor  (TGF), tumor ne-
crosis factor  (TNF), CCR2, CCR4, endothelin receptor
(ET-R), -smooth muscle actin (-SMA), and types I and
III collagen were designed using Primer Express software
(Applied Biosystems, Foster City, CA) and validated for
specificity (Table 1). The differences in the number of
messenger RNA (mRNA) copies in each PCR were cor-
rected for human -actin endogenous control transcript
levels; levels in control experiments were set at 100, and all
other values expressed as multiples thereof.
Enzyme-linked immunosorbent assay. SearchLight
proteome array analyses (Pierce Biotechnology, Woburn,
MA) were conducted to measure the levels of IL-4, IL-6,
IL-17, and TGF in supernatants from AIF-1–expressing
clones, as previously described (36–38). Briefly, samples
were diluted 1:5, 1:50, or 1:1,000 and then incubated for 1
hour on the array plates, which had been prespotted with
capture antibodies specific for each protein. Plates were
decanted and washed 3 times before addition of a cocktail of
biotinylated detection antibodies to each well. After incu-
bation with detection antibodies for 30 minutes, plates were
washed 3 times and incubated for 30 minutes with
streptavidin–horseradish peroxidase. Plates were again
washed, and SuperSignal Femto chemiluminescent substrate
was added. The plates were immediately imaged using the
SearchLight imaging system, and data were analyzed using
ArrayVision software.
Stimulation of cultured fibroblasts with supernatants
from AIF-1 isoform–expressing Jurkat T cells. Equal numbers
of stably transfected Jurkat T cells were collected during their
log phase of growth. Cells were centrifuged for 10 minutes at
1,500 revolutions per minute. Spun cells were processed for
RNA extraction. The supernatants (AIF-1–conditioned me-
dium) were filtered in a 0.22-m filter, aliquoted, and stored at
–20°C until used. Normal fibroblasts from adult forearm skin
were cultured in complete medium in 6-well plates until
confluence. Following preincubation for 24 hours with 40
g/ml ascorbic acid (Sigma), fibroblasts were incubated for 24
hours in complete medium containing supernatants from each
clone (at a 1:2 dilution). Fibroblasts were then harvested and
processed for RNA extraction as described above. Type I
collagen and type III collagen present in the culture media
were quantified by Western blotting using specific anti-human
type I or type III collagen polyclonal antibodies (Rockland,
Gilbertsville, PA). For inhibition experiments, IL-4 neutraliz-
ing antibodies (BioLegend) were used as previously described
(39). Briefly, conditioned supernatants (dilution 1:2) from
AIF-1 isoform 2–expressing Jurkat T cells were preincubated
for 1 hour at 37°C with or without anti–IL-4 antibodies at a
5-g/ml final concentration and then used for stimulation
experiments.
Statistical analysis. The statistical significance of the
data was assessed by Student’s 2-tailed t-test. P values less than
0.05 were considered significant. The raw number of trans-
fected Jurkat T cells migrating toward the fibroblast monolayer
in cell migration experiments was analyzed by repeated-
measures analysis of variance (ANOVA). Additionally, single
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conditions were subjected to Bonferroni adjustment for mul-
tiple comparisons.
RESULTS
Preparation of AIF-1 isoform expression vectors
and stable transfection of Jurkat T cells. Several T cell
lines were screened by real-time PCR to compare
their AIF-1 isoform expression levels with those of
PBMCs. All immortalized cell lines screened showed
higher expression of AIF-1 isoform 1 compared with
PBMCs (data not shown). The Jurkat T cell line I-32
displayed expression levels of AIF-1 isoforms 2 and 3
comparable with those of normal unstimulated
PBMCs (Figure 1A) and was therefore selected for
transfection. Transfection with empty vector did not
affect AIF-1 isoform expression. Clones expressing
high levels of AIF-1 isoforms 2 and 3 were identified
by real-time PCR, selected, and pooled according to
isoform specificity expression, and were used for
further experiments (Figure 1B).
AIF-1 isoform 2 or 3 expression increases T
lymphocyte migration toward fibroblast monolayers
in vitro. Jurkat T cell lines stably transfected with an
empty vector or with the vector expressing either
isoform 2 or isoform 3 were assayed in migration
experiments. The fibroblast monolayer itself induced
Jurkat T cell migration, with a mean  SD of 23.5 
4.27 cells/hpf migrating toward the fibroblast mono-
layer during the first 6 hours, whereas only 10.3  2.02
cells/hpf migrated toward medium alone (P  0.008).
The migration of Jurkat T cells transfected with the
empty vector was not different than the migration of
nontransfected cells (Figure 2A). In contrast, Jurkat T
cells expressing either AIF-1 isoform 2 or AIF-1
isoform 3 displayed a marked increase in migration
toward the fibroblast monolayer (Figure 2B).
Quantitation of the effects of AIF-1 isoform
expression on T cell migration showed that at the 3-hour
time point, 15  2.5 empty vector–transfected Jurkat T
cells/hpf (mean  SD) migrated toward the fibroblast
monolayer, versus 51  5.1 AIF-1 isoform 2–expressing
cells/hpf and 41  4.0 AIF-1 isoform 3–expressing
cells/hpf (Figure 2C). At the 6-hour time point, 24  5.9
empty vector–transfected Jurkat cells/hpf migrated to-
ward the fibroblast monolayer, compared with 121 
15.2/hpf and 59  15.8/hpf for AIF-1 isoform 2– and
AIF-1 isoform 3–expressing cells, respectively (Figure
2C). The differences were highly significant when ana-
lyzed by repeated-measures ANOVA (P  0.0001). At
the 3-hour time point, AIF-1 isoform 2– and AIF-1
isoform 3–expressing cells displayed, respectively, 2.1-
fold and 1.7-fold increased migration compared with
empty vector–transfected cells, and at 6 hours, the
increases were 7.0-fold and 3.83-fold, respectively (P 
0.05 for all) (Figure 2D).
Up-regulation of CCR2 receptor expression is
not responsible for AIF-1–mediated enhancement of T
cell migration. To investigate the mechanisms of AIF-
1–induced enhancement of T cell migration, the expres-
sion of chemokine receptor genes for CCR2 and
CXCR4, functional receptors present on the cell surface
of Jurkat T cells (21,39), was studied. CXCR4 gene
expression was not affected by AIF-1 isoform 2 expres-
sion, whereas it was down-regulated by AIF-1 isoform 3
expression, compared with empty vector–transfected
Figure 1. A, Similar levels of expression of allograft inflammatory
factor 1 (AIF-1) isoforms 2 and 3 by Jurkat T cells and peripheral
blood mononuclear cells (PBMCs). PBMCs and I-32 Jurkat T cells
were processed for RNA extraction as described in Materials and
Methods, and expression of AIF-1 isoforms was measured by real-time
polymerase chain reaction (PCR). The mean expression level of each
AIF-1 isoform in PBMCs from 3 different donors was arbitrarily set at
100, and Jurkat cell expression levels were expressed as multiples
thereof. All real-time PCRs were performed in triplicate. Values are
the mean and SD and are representative of 3 different experiments. B,
Selective expression of AIF-1 isoform 2 or AIF-1 isoform 3 by stable
transfectants, as measured by real-time PCR. Levels in nontransfected
Jurkat cells were arbitrarily set at 100, and the other values expressed
as multiples thereof. PCRs were performed in triplicate. Values are
the mean and SD and are representative of 3 different experiments.
  P  0.001 versus expression levels of the same isoform in
experiments with empty vector.
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cells (Figure 3A). In contrast, CCR2 expression was
strongly up-regulated in AIF-1 isoform 3–expressing
cells (2-fold increase), whereas isoform 2–expressing
cells displayed only 20% higher levels of CCR2 mRNA
compared with empty vector–transfected controls (Fig-
ure 3A). To investigate whether the up-regulation of
CCR2 mRNA was responsible for the observed increase
in the migration of the transfected cells, inhibition
experiments using MCP-1 neutralizing antibodies were
performed as previously described (40). Blocking of
MCP-1–CCR2 interaction did not affect the rate of
migration of AIF-1 isoform 3–expressing cells toward
normal fibroblast monolayers. Representative images
from the Transwell lower chamber following 6-hour
incubation are shown in Figure 3B, and the quantitative
assessment of migrating T cells is shown in Figure 3C.
Figure 2. Allograft inflammatory factor 1 (AIF-1) increases Jurkat T cell migration toward a fibroblast
monolayer. A, Induction of Jurkat T cell migration toward fibroblast monolayers. Migration toward medium
alone or toward a fibroblast monolayer in nontransfected Jurkat T cells (solid bars) and empty vector stable
transfectants (open bars) was measured as described in Materials and Methods. Following 6-hour incubation,
6 random high-power fields (hpf) (200) were photographed, and cells counted. Values are the mean and
SD.   P  0.008. NS  not significant. B, Findings in Transwell lower chambers following 6-hour
incubation. Representative hpf photographs of empty vector–transfected cells, AIF-1 isoform 2–transfected
cells, and AIF-1 isoform 3–transfected cells are shown. Note the spindle-shaped fibroblast monolayer in the
lower chamber. Jurkat cells are visible by phase-contrast microscopy as shining dots (original magnifica-
tion 200). C, Number of stably transfected Jurkat cells migrating into the lower chamber following 3 hours
and 6 hours of incubation. Open squares  empty vector–transfected cells; solid squares  AIF-1 isoform
2–expressing cells; triangles  AIF-1 isoform 3–expressing cells. Values are the mean  SD from 6 hpf and
are representative of 3 different experiments. P  0.0001 for all comparisons by repeated-measures analysis
of variance. For comparisons among single groups after Bonferroni correction,   P  0.01;   P 
0.001. D, Increase in the number of AIF-1 isoform 2– and AIF isoform 3–expressing cells (shaded bars and
solid bars, respectively) migrating toward the fibroblast monolayer, compared with cells stably transfected
with empty vector (open bars). The number of empty vector–transfected cells migrating toward the fibroblast
monolayer at 3 hours was arbitrarily set at 1, and the mean and SD fold increase compared with this value
(in 6 different hpf) was calculated.   P  0.05.
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AIF-1 isoform 2 and AIF-1 isoform 3 up-
regulation of cytokine production by Jurkat T cells.
Stably transfected Jurkat T cells were analyzed for IL-4,
IL-6, IL-10, IL-17, TGF, IFN, and TNF mRNA
expression. AIF-1 isoform 2–expressing cells displayed a
700% increase in IL-4 expression and a 300% increase in
IL-17 expression, whereas TGF mRNA expression was
only modestly up-regulated (40%). In contrast, AIF-1
isoform 3–expressing cells exhibited a slight down-
regulation of IL-4 and IL-17 expression and did not
show any significant change in TGF expression (Figure
3D). IL-6, IL-10, TNF, and IFN levels in AIF-1
isoform 2– or isoform 3–expressing cells were similar to
those in empty vector–transfected cells (data not
shown).
Multiplex enzyme-linked immunosorbent assay
of the actual concentrations of IL-4, IL-6, IL-17, and
TGF in the supernatants from the transfected cells
showed that supernatants from AIF-1 isoform
2–expressing cells had higher levels of IL-4 and IL-17
Figure 3. A, Chemokine receptor gene expression in allograft inflammatory factor 1 (AIF-1) transfectants. CCR2
and CXCR4 gene expression levels were measured by real-time polymerase chain reaction (PCR). Values are the
mean and SD.   P  0.05;   P  0.001. NS  not significant. B and C, Lack of effect of blocking the
monocyte chemotactic protein 1 (MCP-1)–CCR2 interaction on AIF-1 transfectant migration. AIF-1 isoform
3–expressing cells that were not preincubated (control [CTRL]) or were preincubated with neutralizing
anti–MCP-1 antibody were assayed for migration toward a fibroblast monolayer. Qualitative results are shown in
B (photomicrographs representative of 6 different high-power fields [hpf]), and quantitative results (mean and SD
from 6 different hpf) in C. D, Effects of AIF-1 isoforms on cytokine gene expression by Jurkat T cells. Interleukin-4
(IL-4), IL-17, and transforming growth factor  (TGF) gene expression was measured by real-time PCR. PCRs
were performed in triplicate. Values are the mean and SD from 3 different experiments. E, Levels of IL-4, IL-6,
IL-17, and TGF in supernatants from the same experiments shown in D, measured by enzyme-linked
immunosorbent assay. Reactions were conducted on 2 different supernatants, each in duplicate and in 3 different
dilutions as described in Materials and Methods. Values are the mean and SD. Arrow shows the threshold of
detection. In A and C–E, open bars  empty vector transfectants, shaded bars  AIF-1 isoform 2–expressing cells,
and solid bars  AIF isoform 3–expressing cells. In A and D, gene expression levels in empty vector transfectants
were arbitrarily set at 100, and values in AIF-1 isoform 2– and AIF isoform 3–expressing cells were expressed as
multiples thereof.
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(5.0 pg/ml and 2.6 pg/ml, respectively) compared with
either empty vector– or isoform 3–expressing cells, in
which both were undetectable. In contrast, IL-6 was
undetectable in all 3 supernatants, and TGF protein
levels were essentially unchanged (6.1 ng/ml in the
empty vector–transfected supernatants, and 4.5 and 5.0
ng/ml in the isoform 2– and isoform 3–transfected
supernatants, respectively) (Figure 3E).
Conditioned media from AIF-1 isoform 2– or
AIF-1 isoform 3–overexpressing Jurkat T cells increases
collagen production by normal fibroblasts in vitro. We
next examined whether secreted products from AIF-1
Figure 4. Conversion of normal fibroblasts to fibroblasts with a profibrotic phenotype induced by conditioned
media from AIF-1–expressing Jurkat T cells. A, Fibroblast mRNA levels measured by real-time PCR following
24-hour incubation with conditioned medium from Jurkat T cells expressing either empty vector, AIF-1 isoform
2 (ISOF2), or AIF-1 isoform 3, as described in Materials and Methods. Levels of mRNA for COL1A1 (solid bars)
and COL3A1 (shaded bars) in fibroblasts stimulated with conditioned medium from empty vector–transfected
cells were arbitrarily set at 100, and the other values expressed as multiples thereof. Values are the mean and SD
from 3 different PCRs and are representative of 3 different experiments. B, Western blot analysis of type I
collagen (COL I) and type III collagen in fibroblast culture media following incubation with conditioned media
from empty vector–transfected cells or AIF-1 isoform 2–expressing cells. C, Fibroblast expression of IL-6, TGF,
and endothelin receptor (ET-R) measured by real-time PCR following 24-hour stimulation with conditioned
media from either empty vector–, AIF-1 isoform 2–, or AIF-1 isoform 3–transfected Jurkat T cells. Values are
the mean and SD from 3 different PCRs and are representative of 3 different experiments. D, Fibroblast
expression of matrix metalloproteinase 1 (MMP-1) and -smooth muscle actin (-SMA) measured by real-time
PCR as described in C. Values are the mean and SD from 3 different PCRs and are representative of 3 different
experiments. In C and D, open bars  empty vector transfectants, shaded bars  AIF-1 isoform 2–expressing
cells, and solid bars  AIF isoform 3–expressing cells; gene expression levels in empty vector transfectants were
arbitrarily set at 100, and values in AIF-1 isoform 2– and AIF isoform 3–expressing cells were expressed as
multiples thereof.   P  0.05;   P  0.005;   P  0.001, versus empty vector. See Figure 3 for other
definitions.
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isoform 2– or isoform 3–expressing T cells would induce
a change in the phenotype of normal fibroblasts to one
resembling that expressed by SSc fibroblasts. The results
showed that AIF-1 isoform 2–conditioned media caused
an average increase of 300 % in COL1A1 mRNA
expression and of 200% in COL3A1 mRNA expres-
sion, whereas AIF-1 isoform 3 increased COL1A1 ex-
pression by 66% and did not affect COL3A1 mRNA
expression (Figure 4A). Western blotting studies re-
vealed that these mRNA results were reflected at the
level of collagen production (Figure 4B).
Induction of IL-6, TGF, ET-R, and -SMA
expression in normal fibroblasts by conditioned media
from AIF-1 isoform 2–overexpressing Jurkat T cells.
Normal fibroblast cell lines cultured with conditioned
media from either AIF-1 isoform 2– or AIF-1 isoform
3–transfected Jurkat T cells or with conditioned media
from Jurkat T cells transfected with empty vector were
analyzed for expression of genes indicative of a profi-
brotic phenotype. AIF-1 isoform 2–conditioned media
strongly up-regulated the expression of IL-6 and TGF
genes (342% and 353 %, respectively). The expression of
ET-R and -SMA was also increased (400% and 130%,
respectively) (Figures 4C and D). In contrast, matrix
metalloproteinase 1 (MMP-1) levels were not signifi-
cantly changed (Figure 4D). AIF-1 isoform
3–conditioned media did not up-regulate either IL-6,
TGF, or ET-R mRNA levels, whereas both -SMA
and MMP-1 mRNA levels were down regulated (by 61%
and 80%, respectively) (Figure 4D).
AIF-1 isoform 2–conditioned media induce fibro-
blast activation independently of IL-4 secretion. To
analyze whether the fibroblast activation described
above was mediated by the observed increase in IL-4
Figure 5. Confirmation that induction of fibroblast activation by AIF-1 isoform 2 (Iso 2)–conditioned media is
independent of IL-4 secretion. A, Real-time PCR analysis of COL1A1 mRNA levels in fibroblasts following
24-hour stimulation with conditioned media from AIF-1 isoform 2 transfectants with or without preincubation
with neutralizing anti–IL-4 antibody. COL1A1 mRNA levels in fibroblasts stimulated with conditioned media
from AIF-1 isoform 2–expressing cells were up-regulated by 260% without anti–IL-4 preincubation and by 236%
with anti–IL-4 preincubation. Values are the mean and SD from 3 different PCRs and are representative of 3
different experiments. B, Western blot analysis of type I collagen (Col I) in tissue culture media from the same
experiments shown in A. C, Real-time PCR analysis of IL-6 and TGF mR levels assessed as described in A.
Values are the mean and SD from 3 different PCRs and are representative of 3 different experiments.  P
0.001. In A and C, gene expression levels in empty vector transfectants were arbitrarily set at 100, and values in
AIF-1 isoform 2–expressing cells were expressed as multiples thereof. See Figure 3 for other definitions.
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production (Figures 3D and E), IL-4 inhibition experi-
ments were performed. Real-time PCR analysis showed
that the stimulatory effect of AIF-1 isoform
2–conditioned media on COL1A1 mRNA levels was not
affected by the presence of neutralizing IL-4 antibodies
(Figure 5A). This was confirmed at the collagen produc-
tion level by Western blot analysis of fibroblast culture
supernatants (Figure 5B). We next investigated whether
IL-4 inhibition abrogated the observed up-regulation of
IL-6 and TGF in normal fibroblasts following culture
with AIF-1 isoform 2–conditioned media. Neutralizing
IL-4 antibodies failed to inhibit the potent up-regulation
of IL-6 or TGF mRNA levels (290% and 240%,
respectively) caused by AIF-1 isoform 2 supernatants
compared with media from empty vector–transfected
cells (P  0.001 for both) (Figure 5C).
DISCUSSION
We recently demonstrated that T cells infiltrating
the skin and lungs of SSc patients, as well as mono-
nuclear cells within the neointima of pulmonary arteries
of patients with SSc-related pulmonary hypertension,
express high levels of AIF-1 (28). In this study we
investigated whether AIF-1 expression in T cells could
affect their ability to migrate toward fibroblast mono-
layers and/or induce their production of profibrogenic
cytokines and growth factors. Due to well-known tech-
nical limitations inherent in the establishment of stable
transfectants of normal human PBMCs, which include
the length of the selection procedures, the limited
survival of primary PBMCs in vitro in the absence of
cytokine stimulation, and their genetic heterogeneity, we
chose to study immortalized T cell lines, which are a
homogeneous and virtually unlimited source of func-
tional T cells. We used the CD4 Jurkat T cell line I-32,
which exhibited AIF-1 isoform 2 and AIF-1 isoform 3
expression similar to that of normal unstimulated PB-
MCs.
Analysis of the role of the various AIF-1 isoforms
in Jurkat T cell migration toward a fibroblast monolayer
showed that, consistent with previous findings by Kele-
men and Autieri (41), AIF-1 isoform 3 promoted T cell
migration. More importantly, AIF-1 isoform 2 promoted
an even higher rate of migration. This observation is of
substantial relevance, since AIF-1 isoform 2 is the
splicing variant that we previously found to be selectively
up-regulated by TGF (28), and harbors a single-nucleo-
tide polymorphism that is highly expressed in SSc
(31,32).
T cells migrate toward various stimuli through
signals transduced mainly by chemokine receptors.
MCP-1 and stromal cell–derived factor 1 are 2 chemo-
kines known to be up-regulated in SSc lesions and are
produced by fibroblasts; therefore, they are believed to
mediate the tissue infiltration by inflammatory cells in
SSc (21,22). To investigate whether AIF-1–induced en-
hancement of T cell migration involves MCP-1, we
performed inhibition studies using specific antibodies.
The results showed that MCP-1 blockage did not have
any effect on T cell migration.
After observing that AIF-1 was able to affect T
cell migration, we hypothesized that AIF-1 expression
could play a critical role in other aspects of T cell
activation as well, such as cytokine production. Indeed,
we found that AIF-1 isoform 2 up-regulated the expres-
sion of IL-4 and IL-17 mRNA and increased the pro-
duction of both cytokines. In contrast, levels of IFN
and TNF mRNA were not increased by either AIF-1
isoform 2 or AIF-1 isoform 3.
Since previous studies indicated that in vivo
AIF-1–expressing T cells are in close proximity to acti-
vated skin fibroblasts (28), we next examined the effect
of conditioned media from AIF-1–expressing Jurkat T
cells on normal dermal fibroblast function. We per-
formed coculture experiments under conditions that
avoided the cell–cell contact of functional Jurkat T cells
with HLA-mismatched fibroblasts that could potentially
produce a T cell activation driven by allogenic diversity.
We observed a robust and consistent increase in the
production of types I and III collagen following 24 hours
of stimulation with conditioned media from AIF-1 iso-
form 2–expressing T cells. This effect, evident at the
protein level, was accompanied by a substantial increase
in COL1A1 and COL3A1 mRNA levels and by a
marked increase in levels of mRNA for IL-6, TGF,
ET-R, and -SMA, all considered to be markers of
fibroblast activation (3,42–44).
To further investigate whether the profibrotic
activation of normal fibroblasts demonstrated in vitro
following stimulation with conditioned media from AIF-
1–expressing cells was directly caused by the observed
increase in IL-4 production, neutralization experiments
were performed. The results (Figure 5) demonstrated
that inhibition of IL-4 with specific antibodies did not
have any significant effect either on collagen production
or on cytokine mRNA levels in normal human dermal
fibroblasts. Therefore, the observed profibrotic effect of
AIF-1 isoform 2–expressing cells is not directly caused
by IL-4. Further studies are in progress to identify the
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cytokine(s) or growth factor(s) responsible for the ob-
served effects on fibroblast function.
In conclusion, we have shown in this study that
AIF-1 can induce T cell migration toward normal der-
mal fibroblasts, indicating that AIF-1 expression by T
cells can promote their tissue infiltration. Furthermore,
we have demonstrated that AIF-1 expression by T cells
can induce activation of normal fibroblasts, increasing
their collagen production and the expression of several
markers of fibrosis including IL-6, TGF, -SMA, and
ET-R, while at the same time causing a reduction in
their MMP-1 expression. Further understanding of the
mechanisms by which AIF-1 can promote increased T
cell migration and cytokine production, and identifica-
tion of the cytokines produced by AIF-1–expressing cells
that are responsible for the potent profibrotic effect on
normal fibroblasts observed herein, will shed light on the
interplay between T cells and fibroblasts in the early
phase of SSc pathogenesis and on the role of AIF-1 in
this process.
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